SMBC集團、富士通與軟銀達成業務合作協議，將建構日本國產健康醫療平台以實現可持續發展的醫療服務

SMBC集團、富士通與軟銀三方達成合作，將建立一個利用醫療與健康數據的日本國產健康醫療平台，旨在延長國民的健康壽命並抑制醫療費用。
Business PartnershipNQ 95/100出典：PR Times

📋 文章處理履歷

  • 📰 發表: 2026年5月19日 22:00
  • 🔍 收集: 2026年5月19日 13:31
  • 🤖 AI分析完成: 2026年5月21日 15:25（收集後49小時53分鐘）
三井住友金融集團（SMBC集團）、富士通及軟銀三家公司已簽訂基本協議，將在健康與醫療領域進行業務合作，以確保日本醫療體系的可持續性。此合作旨在建立一個日本國產的健康醫療基礎設施，包含一個在個人同意下安全管理與利用醫療數據的平台，以及一個搭載AI代理的用戶應用程式。此舉將整合日常健康管理到院後追蹤的服務，促進個人健康並改變行為模式，目標是為未來抑制高達5兆日圓的醫療費用增長做出貢獻。

常見問題

Which companies are involved in this healthcare partnership?

The partnership involves three companies: SMBC Group, Fujitsu Limited, and SoftBank Corp.

What is the main objective of this alliance?

The main objective is to build a domestic healthcare platform to make Japan's healthcare system sustainable by extending healthy life expectancy, improving the operational efficiency of medical institutions, and helping to control national medical expenses.

What will the new healthcare platform consist of?

It will consist of a data platform to securely manage and utilize medical data, and a user application featuring an AI agent that provides personalized health support by combining medical and personal health data with user consent.

What are the roles of each company in this partnership?

SMBC Group will focus on user acquisition and integrating financial services. Fujitsu will lead the development of the data platform and medical AI. SoftBank will lead the development of the user application, leveraging its large user base.

What are the long-term goals of this initiative?

The companies aim to expand the platform's user base to 60 million people, introduce it to 4,000 medical institutions, and contribute to curbing future medical cost increases by an estimated 5 trillion yen.

返回 Newsroom (51)